1 results match your criteria: "Centre de Physiopathologie Toulous Purpan[Affiliation]"
Cell Cycle
August 2003
Département Innovation Thérapeutic et Oncologie Moléculaire, Centre de Physiopathologie Toulous Purpan, INSERM U563, Institut Claudius Regaud, France.
Here we demonstrate that the geranylgeranyltransferase-I inhibitor GGTI-298 inhibits the RhoB pathway and disrupts stress fiber and focal adhesion formation in NIH-3T3 cells. Farnesylated (V14)RhoB-CAIM (resistant to GGTI-298), but not geranylgeranylated (V14)RhoB (-CLLL), prevented inhibition of actin stress fiber and focal adhesion formation, underlining the critical role of RhoB. In contrast, farnesylated, (V14)RhoA (-CVLS) was unable to prevent effects of GGTI 298 on cytoskeleton organization.
View Article and Find Full Text PDF